Login

Switch On Your HIV Smarts.

PrEP advocate Damon Jacobs: Vaping can be harm reduction

PrEP advocate Damon Jacobs: Vaping can be harm reduction

, by Damon Jacobs

There’s a flaw in San Francisco’s plan to ban flavored tobacco products, and it may have negative consequences for people who use vaping products to quit smoking cigarettes. Read More

Ending hepatitis C means including people who inject drugs

Ending hepatitis C means including people who inject drugs

, by Emily Land

Innovative HCV cure initiatives in San Francisco prioritize high-needs people who may still be actively injecting drugs. Read More

CROI 2018: A roundup of the most exciting PrEP news & research

CROI 2018: A roundup of the most exciting PrEP news & research

, by Liz Highleyman

Liz Highleyman summarizes the PrEP and HIV prevention research presented recently at the domestic HIV conference, CROI, including a new possible PrEP drug, real world PrEP effectiveness, and more. Read More

Status check: PrEP uptake & delivery

Status check: PrEP uptake & delivery

, by Emily Land

Dr. Kenneth Mayer discusses the state of PrEP uptake and delivery in the U.S., with an eye toward reducing barriers for people who may benefit from this method of HIV prevention. Read More

Biktarvy, a new HIV combo pill recently approved by the FDA

Biktarvy, a new HIV combo pill recently approved by the FDA

, by Jennifer Cocohoba, PharmD, AAHIVE

This week, the FDA granted approval of Gilead Science’s single-table combo pill of bictegravir, emtricitabine, and tenofovir alafenamide named Biktarvy. Read More